Artículos de revistas sobre el tema "INTERFERONOPATIA"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "INTERFERONOPATIA".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Souza, Victória Cabral de, Roberto de Barros Silva y Caique Antunis. "INTERFERON-I COMO ALVO TERAPÊUTICO NO TRATAMENTO DO LÚPUS ERITEMATOSO SISTÊMICO: USO DOS ANTICORPOS MONOCLONAIS ANIFROLUMABE, RONTALIZUMABE E SIFALIMUMABE". Revista Ibero-Americana de Humanidades, Ciências e Educação 9, n.º 1 (31 de enero de 2023): 717–31. http://dx.doi.org/10.51891/rease.v9i1.8303.
Texto completoTommasini, Alberto, Irene Bruno, Maria Elisa Morelli y Loredana Lepore. "Le interferonopatie di tipo I". Medico e Bambino 40, n.º 8 (23 de septiembre de 2021): 509–14. http://dx.doi.org/10.53126/meb40509.
Texto completoPayet, Cloé A., Axel You, Odessa-Maud Fayet, Nadine Dragin, Sonia Berrih-Aknin y Rozen Le Panse. "Myasthenia Gravis: An Acquired Interferonopathy?" Cells 11, n.º 7 (4 de abril de 2022): 1218. http://dx.doi.org/10.3390/cells11071218.
Texto completoBriggs, Tracy A., Anindita Paul, Gillian Rice y Ariane L. Herrick. "RNASEH2B Related Adult-Onset Interferonopathy". Journal of Clinical Immunology 39, n.º 6 (31 de julio de 2019): 620–22. http://dx.doi.org/10.1007/s10875-019-00673-w.
Texto completoRodero, Mathieu P., Marie-Louise Frémond, Gillian I. Rice, Bénédicte Neven y Yanick J. Crow. "JAK inhibition in STING-associated interferonopathy". Annals of the Rheumatic Diseases 75, n.º 12 (12 de octubre de 2016): e75-e75. http://dx.doi.org/10.1136/annrheumdis-2016-210504.
Texto completoManoussakis, Menelaos N., Clio P. Mavragani, Adrianos Nezos, Evangelia Zampeli, Anastassios Germenis y Haralampos M. Moutsopoulos. "Type I interferonopathy in a young adult". Rheumatology 56, n.º 12 (14 de agosto de 2017): 2241–43. http://dx.doi.org/10.1093/rheumatology/kex316.
Texto completoKrieger, Ben Zion, Theresa Calvelli, Anna Kadish y Arye Rubinstein. "1042 INTERFERONOPATHY IN THE BARE LYMPHOCYTE SYNDROME". Pediatric Research 19, n.º 4 (abril de 1985): 284A. http://dx.doi.org/10.1203/00006450-198504000-01072.
Texto completoPiotto, Daniela Gerent Petry, Kátia Tomie Kozu y Sandro Félix Perazzio. "Quando suspeitar de doenças autoinflamatórias na infância?" Reumatologia Pediátrica, n.º 2021 jan-mar;20(1) (31 de marzo de 2021): 16–26. http://dx.doi.org/10.46833/reumatologiasp.2021.20.1.16-26.
Texto completoCrow, Yanick, Nandaki Keshavan, Jacques Patrick Barbet, Geanina Bercu, Vincent Bondet, Charlotte Boussard, Nathalie Dedieu et al. "Cardiac valve involvement in ADAR-related type I interferonopathy". Journal of Medical Genetics 57, n.º 7 (26 de noviembre de 2019): 475–78. http://dx.doi.org/10.1136/jmedgenet-2019-106457.
Texto completoKozlova, A. L., E. S. Romanenko, V. I. Burlakov, E. V. Deripapa, Sv P. Khomyakova, A. N. Remizov, G. V. Tereshenko y A. Yu Shcherbina. "CLINICAL CASE OF TYPE I INTERFERONOPATHY: AICARDI–GOUTIERES SYNDROME". Pediatria. Journal named after G.N. Speransky 98, n.º 3 (10 de junio de 2019): 257–65. http://dx.doi.org/10.24110/0031-403x-2019-98-3-257-265.
Texto completoManzano, Giovanna S., Jared K. Woods y Anthony A. Amato. "Covid-19–Associated Myopathy Caused by Type I Interferonopathy". New England Journal of Medicine 383, n.º 24 (10 de diciembre de 2020): 2389–90. http://dx.doi.org/10.1056/nejmc2031085.
Texto completoCrow, Yanick J. y Jean-Laurent Casanova. "STING-Associated Vasculopathy with Onset in Infancy — A New Interferonopathy". New England Journal of Medicine 371, n.º 6 (7 de agosto de 2014): 568–71. http://dx.doi.org/10.1056/nejme1407246.
Texto completoTüngler, Victoria, Nadja König, Claudia Günther, Kerstin Engel, Christoph Fiehn, Martin Smitka, Maja von der Hagen, Reinhard Berner y Min Ae Lee-Kirsch. "Response to: ‘JAK inhibition in STING-associated interferonopathy’ by Crowet al". Annals of the Rheumatic Diseases 75, n.º 12 (3 de noviembre de 2016): e76-e76. http://dx.doi.org/10.1136/annrheumdis-2016-210565.
Texto completoPicard, Cécile, Guillaume Thouvenin, Caroline Kannengiesser, Jean-Christophe Dubus, Nadia Jeremiah, Frédéric Rieux-Laucat, Bruno Crestani et al. "Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation)". Chest 150, n.º 3 (septiembre de 2016): e65-e71. http://dx.doi.org/10.1016/j.chest.2016.02.682.
Texto completoGoldmann, Tobias, Nicolas Zeller, Jenni Raasch, Katrin Kierdorf, Kathrin Frenzel, Lars Ketscher, Anja Basters et al. "USP 18 lack in microglia causes destructive interferonopathy of the mouse brain". EMBO Journal 34, n.º 12 (20 de abril de 2015): 1612–29. http://dx.doi.org/10.15252/embj.201490791.
Texto completoRafat, Cédric y Alice Doreille. "Could Plasmodium falciparum–related kidney disease stand as another example of interferonopathy?" Kidney International 102, n.º 3 (septiembre de 2022): 669–70. http://dx.doi.org/10.1016/j.kint.2022.06.009.
Texto completoKozlova, А. L., М. Е. Leonteva, V. I. Burlakov, Z. А. Nesterenko, О. М. Laba, М. V. Pisareva, N. Yu Kan et al. "Clinical case of type I interferonopathy: homozygous STAT2 gain-of-function mutation". Pediatric Hematology/Oncology and Immunopathology 20, n.º 3 (8 de octubre de 2021): 132–39. http://dx.doi.org/10.24287/1726-1708-2021-20-3-132-139.
Texto completoFrémond, M.-L., C. Gitiaux, D. Bonnet, T. Guiddir, Y. Crow, L. de Ponthual y B. Bader-Meunier. "Mosaic tetrasomy 9p: a mendelian interferonopathy associated with pediatric-onset overlap myositis". Pediatric Rheumatology 13, Suppl 1 (2015): P140. http://dx.doi.org/10.1186/1546-0096-13-s1-p140.
Texto completoMeuwissen, Marije E. C., Rachel Schot, Sofija Buta, Grétel Oudesluijs, Sigrid Tinschert, Scott D. Speer, Zhi Li et al. "Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome". Journal of Experimental Medicine 213, n.º 7 (20 de junio de 2016): 1163–74. http://dx.doi.org/10.1084/jem.20151529.
Texto completoEmralino, Francine Lianne, Saya Satoh, Nobuhiro Sakai, Masamichi Takami, Fumihiko Takeuchi, Nan Yan, Frank Rutsch, Takashi Fujita y Hiroki Kato. "Double-Stranded RNA Induces Mortality in an MDA5-Mediated Type I Interferonopathy Model". Journal of Immunology 209, n.º 11 (1 de diciembre de 2022): 2093–103. http://dx.doi.org/10.4049/jimmunol.2200367.
Texto completoSifuentes-Dominguez, Luis, Petro Starokadomskyy, Jacob Welch, Bhaskar Gurram, Jason Y. Park, Prasad Koduru y Ezra Burstein. "Mosaic Tetrasomy 9p Associated With Inflammatory Bowel Disease". Journal of Crohn's and Colitis 13, n.º 11 (25 de abril de 2019): 1474–78. http://dx.doi.org/10.1093/ecco-jcc/jjz079.
Texto completoKomura, Kazuhiro, Yuki Ichimura, Naoko Okiyama, Kazuyoshi Watanabe, Hiroaki Muramoto y Takashi Matsushita. "Interferon signature in cutaneous lesion of COVID toes". Journal of Immunology 206, n.º 1_Supplement (1 de mayo de 2021): 20.37. http://dx.doi.org/10.4049/jimmunol.206.supp.20.37.
Texto completoHauck, Fabian. "Angeborene autoinflammatorische Störungen der cGAS-STING- und OASRNase-L-vermittelten Nukleinsäure-Immunität". Translationale Immunologie 5, n.º 3 (28 de octubre de 2021): 160–65. http://dx.doi.org/10.47184/ti.2021.03.04.
Texto completoOkada, Yuri, Rumiko Izumi, Tatsuhiko Hosaka, Satoshi Watanabe, Tomomi Shijo, Naokazu Hatchome, Risa Konishi et al. "Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy". Rheumatology 61, n.º 4 (30 de noviembre de 2021): e90-e92. http://dx.doi.org/10.1093/rheumatology/keab872.
Texto completoRuggeri, Paolo y Gaetano Caramori. "Interferonopathy: a potential link between innate immunity and autoimmunity in the pathogenesis of COPD". American Journal of Physiology-Lung Cellular and Molecular Physiology 317, n.º 6 (1 de diciembre de 2019): L888—L890. http://dx.doi.org/10.1152/ajplung.00439.2019.
Texto completode Jesus, Adriana A., Anja Brehm, Rachel VanTries, Pascal Pillet, Anne-Sophie Parentelli, Gina A. Montealegre Sanchez, Zuoming Deng, Isabelle Koné Paut, Raphaela Goldbach-Mansky y Elke Krüger. "Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4". Journal of Allergy and Clinical Immunology 143, n.º 5 (mayo de 2019): 1939–43. http://dx.doi.org/10.1016/j.jaci.2018.12.1012.
Texto completoOkada, Satoshi, Takaki Asano, Kunihiko Moriya, Stephanie Boisson-Dupuis, Masao Kobayashi, Jean-Laurent Casanova y Anne Puel. "Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy". Journal of Clinical Immunology 40, n.º 8 (27 de agosto de 2020): 1065–81. http://dx.doi.org/10.1007/s10875-020-00847-x.
Texto completode Carvalho, Luciana Martins, Gonza Ngoumou, Ji Woo Park, Nadja Ehmke, Nikolaus Deigendesch, Naoki Kitabayashi, Isabelle Melki et al. "Musculoskeletal Disease in MDA5-Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's Arthropathy". Arthritis & Rheumatology 69, n.º 10 (22 de agosto de 2017): 2081–91. http://dx.doi.org/10.1002/art.40179.
Texto completoAl-Mayouf, Sulaiman M., Lujayn Akbar, Abdullatif AlEnazi y Hamoud Al-Mousa. "Autosomal Recessive ISG15 Deficiency Underlies Type I Interferonopathy with Systemic Lupus Erythematosus and Inflammatory Myositis". Journal of Clinical Immunology 41, n.º 6 (19 de marzo de 2021): 1361–64. http://dx.doi.org/10.1007/s10875-021-01019-1.
Texto completoRood, Julia E. y Edward M. Behrens. "Inherited Autoinflammatory Syndromes". Annual Review of Pathology: Mechanisms of Disease 17, n.º 1 (24 de enero de 2022): 227–49. http://dx.doi.org/10.1146/annurev-pathmechdis-030121-041528.
Texto completoKasher, Paul R., Emma M. Jenkinson, Valérie Briolat, David Gent, Catherine Morrissey, Leo A. H. Zeef, Gillian I. Rice, Jean-Pierre Levraud y Yanick J. Crow. "Characterization of samhd1 Morphant Zebrafish Recapitulates Features of the Human Type I Interferonopathy Aicardi-Goutières Syndrome". Journal of Immunology 194, n.º 6 (11 de febrero de 2015): 2819–25. http://dx.doi.org/10.4049/jimmunol.1403157.
Texto completoKong, Xiao-Fei, Lisa Worley, Darawan Rinchai, Vincent Bondet, Puthen Veettil Jithesh, Marie Goulet, Emilie Nonnotte et al. "Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome". Journal of Clinical Immunology 40, n.º 6 (22 de junio de 2020): 807–19. http://dx.doi.org/10.1007/s10875-020-00803-9.
Texto completoDuncan, Christopher J. A., Benjamin J. Thompson, Rui Chen, Gillian I. Rice, Florian Gothe, Dan F. Young, Simon C. Lovell et al. "Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2". Science Immunology 4, n.º 42 (13 de diciembre de 2019): eaav7501. http://dx.doi.org/10.1126/sciimmunol.aav7501.
Texto completoBuers, Insa, Gillian I. Rice, Yanick J. Crow y Frank Rutsch. "MDA5-Associated Neuroinflammation and the Singleton–Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum". Journal of Interferon & Cytokine Research 37, n.º 5 (mayo de 2017): 214–19. http://dx.doi.org/10.1089/jir.2017.0004.
Texto completoMeesilpavikkai, Kornvalee, Willem A. Dik, Benjamin Schrijver, Cornelia G. Helden‐Meeuwsen, Marjan A. Versnel, P. Martin Hagen, Emilia K. Bijlsma, Claudia A. L. Ruivenkamp, Margreet J. Oele y Virgil A. S. H. Dalm. "Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy". Arthritis & Rheumatology 71, n.º 5 (6 de marzo de 2019): 829–31. http://dx.doi.org/10.1002/art.40805.
Texto completoMills, Taylor, Bailee Kain, Erin Lucas, Matt Burchill, Beth Jiron Tamburini, Katherine King y Eric Pietras. "3097 – AUTOIMMUNE INTERFERONOPATHY INDUCES A ‘TRAINED IMMUNITY’ PROGRAM IN HSC THAT PRIMES MACROPHAGES FOR INCREASED PATHOGEN KILLING AND INFLAMMATORY ACTIVITY". Experimental Hematology 100 (agosto de 2021): S89. http://dx.doi.org/10.1016/j.exphem.2021.12.314.
Texto completoCazzato, Salvatore, Alessia Omenetti, Claudia Ravaglia y Venerino Poletti. "Lung involvement in monogenic interferonopathies". European Respiratory Review 29, n.º 158 (15 de diciembre de 2020): 200001. http://dx.doi.org/10.1183/16000617.0001-2020.
Texto completoKataoka, Shinsuke, Nozomu Kawashima, Yusuke Okuno, Hideki Muramatsu, Shunsuke Miwata, Kotaro Narita, Motoharu Hamada et al. "Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor". Journal of Allergy and Clinical Immunology 148, n.º 2 (agosto de 2021): 639–44. http://dx.doi.org/10.1016/j.jaci.2021.03.010.
Texto completoPoeschla, Eric M. y Laura Bankers. "Development of interferon-stimulated gene expression from embryogenesis through adulthood, with and without constitutive MDA5 pathway activation". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 68.15. http://dx.doi.org/10.4049/jimmunol.204.supp.68.15.
Texto completoBryant, Andrew J., Ann Pham, Himanshu Gogoi, Carly R. Mitchell, Faye Pais y Lei Jin. "The Third Man: DNA sensing as espionage in pulmonary vascular health and disease". Pulmonary Circulation 11, n.º 1 (enero de 2021): 204589402199657. http://dx.doi.org/10.1177/2045894021996574.
Texto completoAdang, Laura, Francesco Gavazzi, Micaela De Simone, Elisa Fazzi, Jessica Galli, Jamie Koh, Julia Kramer-Golinkoff et al. "Developmental Outcomes of Aicardi Goutières Syndrome". Journal of Child Neurology 35, n.º 1 (27 de septiembre de 2019): 7–16. http://dx.doi.org/10.1177/0883073819870944.
Texto completoSandling, Johanna K., Pascal Pucholt, Lina Hultin Rosenberg, Fabiana H. G. Farias, Sergey V. Kozyrev, Maija-Leena Eloranta, Andrei Alexsson et al. "Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing". Annals of the Rheumatic Diseases 80, n.º 1 (9 de octubre de 2020): 109–17. http://dx.doi.org/10.1136/annrheumdis-2020-218636.
Texto completoTesser, Alessandra, Giulia Maria Piperno, Alessia Pin, Elisa Piscianz, Valentina Boz, Federica Benvenuti y Alberto Tommasini. "Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons". Cells 10, n.º 4 (1 de abril de 2021): 785. http://dx.doi.org/10.3390/cells10040785.
Texto completoDaou, Salima, Manisha Talukdar, Jinle Tang, Beihua Dong, Shuvojit Banerjee, Yize Li, Nicole M. Duffy et al. "A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency". Proceedings of the National Academy of Sciences 117, n.º 40 (21 de septiembre de 2020): 24802–12. http://dx.doi.org/10.1073/pnas.2006883117.
Texto completoWang, Qingde, Xinfeng Guo, Yi Sheng, Tony Wang, Richard Steinman y Timothy R. Billiar. "An AGS associated mutation causes cellular RNA editing deficiency in mouse brain which lead to IFN pathway activation, mimicking the interferonopathy of patient brains". Journal of Immunology 206, n.º 1_Supplement (1 de mayo de 2021): 15.07. http://dx.doi.org/10.4049/jimmunol.206.supp.15.07.
Texto completoSu, Yu-Jih, Hung-Yu Lin, Shao-Wen Weng, Cheng-Hsien Lu, Ching-Yi Lin, Wen-Chan Chiu y Pei-Wen Wang. "Metformin Represses Interferonopathy Through Suppression of Melanoma Differentiation-Associated Protein 5 and Mitochondrial Antiviral Signaling Protein Activation: Comment on the Article by Wang et al". Arthritis & Rheumatology 68, n.º 12 (28 de noviembre de 2016): 3042–43. http://dx.doi.org/10.1002/art.39935.
Texto completoDavid, Clémence y Marie-Louise Frémond. "Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)". Cells 11, n.º 3 (18 de enero de 2022): 318. http://dx.doi.org/10.3390/cells11030318.
Texto completoYoshikawa, T., K. Azuma, T. Furukawa, M. Tamura, T. Hashimoto, M. Morimoto, N. Azuma y K. Matsui. "AB0311 INCREASED LEVELS OF SERUM WISTERIA FLORIBUNDA AGGLUTININPOSITIVE MAC-2 BINDING PROTEIN IN RHEUMATIC DISEASES INCLUDING SLE". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 1181.1–1181. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1494.
Texto completoStathopoulou, C., D. Konstantopoulos, S. Papanikolaou, G. Vatsellas, G. Panagopoulos, P. Sidiropoulos y G. Bertsias. "POS0404 IFNα-MEDIATED METABOLIC REPROGRAMMING IN HUMAN SLE MONOCYTES INVOLVES PERTURBATIONS IN GLYCOLYTIC AND LIPID METABOLISM TO REGULATE PROINFLAMMATORY MARKERS AND CYTOKINES". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 458.1–458. http://dx.doi.org/10.1136/annrheumdis-2022-eular.2035.
Texto completoPennisi, Alessandra, Agnès Rötig, Charles-Joris Roux, Raphaël Lévy, Marco Henneke, Jutta Gärtner, Pelin Teke Kisa et al. "Heterogeneity of PNPT1 neuroimaging: mitochondriopathy, interferonopathy or both?" Journal of Medical Genetics, 16 de noviembre de 2020, jmedgenet—2020–107367. http://dx.doi.org/10.1136/jmedgenet-2020-107367.
Texto completo